Mineral Resources Limited (ASX: MIN) forecasts developments and production


Wodgina Lithium Project’s development is progressing as expected which is 100% owned by the Company. Commissioning of the spodumene concentrate processing plant remains on target to commence in October 2018. Through to the second quarter of CY 2019, the plant will progressively ramp up production.

Forecast capital costs of the company for the project is expected to be in the order of $610 million, with a significant portion of these costs already been committed. The new crushing plant, the three spodumene concentrate trains, an airport, the gas pipeline and the power station which are the main items of capital expenditure. The plant will have three trains, with the capacity to produce 750,000 dry metric tons of 6% Li?O spodumene concentrate per annum once it is fully commissioned, increasing to approximately 880,000 dry metric tons if 5.5% spodumene concentrate grade is targeted.

In accordance with the Company’s financial guidance update of 11 April 2018 and the pricing estimates in the Company’s ASX announcement of 7 May 2018, the Company’s forecast sale price for 6% spodumene concentrate remains at US$960 per ton. Mineral Resources is trading at $16.985 with a percentage change of +3.19% as at July 24, 2018, before market close.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report